Company co-exhibiting with strategic partner Venture Medical, LLC, highlighting collaborative innovation in chronic wound care management Three scientific posters feature BioStem’s proprietary allograft portfolio POMPANO BEACH, Fla., Sept. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced its agenda for the Symposium for Advanced ...

Core Insights - Dimora Medical has launched the Dimora PHMB Skin and Wound Cleanser to address the challenges of chronic wound care, particularly for aging populations [1][15] - The cleanser effectively tackles biofilms, which complicate over 78% of chronic wounds, by breaking them down and killing 99.99% of bacteria within minutes [1][4][8] Product Features - The main ingredient, Polyhexamethylene Biguanide (PHMB), has demonstrated the ability to remove 99.49% of biofilm within three minutes and 99.99% after seven minutes [5] - The cleanser provides rapid antimicrobial action, killing 99.99% of bacteria in just two minutes for infected wounds and in one minute for non-infected wounds [8][9] - The product maintains its antimicrobial strength over time, achieving a 99.99% reduction in bacteria even after being opened for 28 days [12] Benefits for Caregivers - The cleanser simplifies the wound care process, allowing caregivers to clean and protect wounds quickly without multiple steps [9][15] - It reduces the risk of infection and complications, providing families with greater confidence in managing chronic wounds at home [6][16] - Dimora Medical aims to make home care easier and less stressful for families, positioning itself as a trusted expert in wound care [15][16]